INPEFA 200 MG TABLET sotagliflozin | 70183022130 | $20.3694 per EA | -0.44% | | — | Lexicon Pharmaceuticals, Inc. |
INPEFA 200 MG TABLET sotagliflozin | 70183022131 | $20.3694 per EA | -0.44% | | — | Lexicon Pharmaceuticals, Inc. |
INPEFA 200 MG TABLET sotagliflozin | 70183022030 | $19.7358 per EA | — | | — | Lexicon Pharmaceuticals, Inc. |
XIGDUO XR 10 MG-500 MG TABLET dapagliflozin and metformin hydrochloride | 00310627030 | $19.2391 per EA | +0.07% | | — | AstraZeneca Pharmaceuticals LP |
XIGDUO XR 10 MG-1,000 MG TAB dapagliflozin and metformin hydrochloride | 00310628030 | $19.2044 per EA | +0.02% | | — | AstraZeneca Pharmaceuticals LP |
XIGDUO XR 5 MG-500 MG TABLET dapagliflozin and metformin hydrochloride | 00310625030 | $19.1816 per EA | -0.01% | | — | AstraZeneca Pharmaceuticals LP |
INVOKANA 100 MG TABLET canagliflozin | 50458014030 | $19.1269 per EA | +0.09% | | — | Janssen Pharmaceuticals Inc. |
INVOKANA 100 MG TABLET canagliflozin | 50458014090 | $19.1269 per EA | +0.09% | | — | Janssen Pharmaceuticals Inc. |
INVOKANA 300 MG TABLET canagliflozin | 50458014130 | $19.1248 per EA | +0.03% | | — | Janssen Pharmaceuticals Inc. |
INVOKANA 300 MG TABLET canagliflozin | 50458014190 | $19.1248 per EA | +0.03% | | — | Janssen Pharmaceuticals Inc. |
FARXIGA 10 MG TABLET DAPAGLIFLOZIN | 00310621030 | $12.0770 per EA | 0.00% | | — | AstraZeneca Pharmaceuticals LP |
FARXIGA 10 MG TABLET DAPAGLIFLOZIN | 00310621039 | $12.0770 per EA | 0.00% | | — | AstraZeneca Pharmaceuticals LP |
FARXIGA 10 MG TABLET DAPAGLIFLOZIN | 00310621090 | $12.0770 per EA | 0.00% | | — | AstraZeneca Pharmaceuticals LP |
FARXIGA 5 MG TABLET DAPAGLIFLOZIN | 00310620530 | $12.0758 per EA | 0.00% | | — | AstraZeneca Pharmaceuticals LP |
FARXIGA 5 MG TABLET DAPAGLIFLOZIN | 00310620590 | $12.0758 per EA | 0.00% | | — | AstraZeneca Pharmaceuticals LP |
TRIJARDY XR 10-5-1,000 MG TAB empagliflozin, linagliptin, metformin hydrochloride | 00597038013 | $11.2774 per EA | -0.08% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
TRIJARDY XR 10-5-1,000 MG TAB empagliflozin, linagliptin, metformin hydrochloride | 00597038068 | $11.2774 per EA | -0.08% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
GLYXAMBI 10 MG-5 MG TABLET empagliflozin and linagliptin | 00597018230 | $11.2437 per EA | -0.01% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
GLYXAMBI 10 MG-5 MG TABLET empagliflozin and linagliptin | 00597018239 | $11.2437 per EA | -0.01% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
GLYXAMBI 10 MG-5 MG TABLET empagliflozin and linagliptin | 00597018290 | $11.2437 per EA | -0.01% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
TRIJARDY XR 25-5-1,000 MG TAB empagliflozin, linagliptin, metformin hydrochloride | 00597039013 | $11.2386 per EA | +0.04% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
TRIJARDY XR 25-5-1,000 MG TAB empagliflozin, linagliptin, metformin hydrochloride | 00597039071 | $11.2386 per EA | +0.04% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY XR 10-1,000 MG TABLET empagliflozin, metformin hydrochloride | 00597028073 | $11.2186 per EA | +0.06% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY XR 10-1,000 MG TABLET empagliflozin, metformin hydrochloride | 00597028090 | $11.2186 per EA | +0.06% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
GLYXAMBI 25 MG-5 MG TABLET empagliflozin and linagliptin | 00597016430 | $11.1994 per EA | +0.01% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
GLYXAMBI 25 MG-5 MG TABLET empagliflozin and linagliptin | 00597016439 | $11.1994 per EA | +0.01% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
GLYXAMBI 25 MG-5 MG TABLET empagliflozin and linagliptin | 00597016490 | $11.1994 per EA | +0.01% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY XR 25-1,000 MG TABLET empagliflozin, metformin hydrochloride | 00597029578 | $11.1929 per EA | -0.01% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY XR 25-1,000 MG TABLET empagliflozin, metformin hydrochloride | 00597029588 | $11.1929 per EA | -0.01% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
JARDIANCE 25 MG TABLET Empagliflozin | 00597015330 | $11.1897 per EA | +0.04% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
JARDIANCE 25 MG TABLET Empagliflozin | 00597015337 | $11.1897 per EA | +0.04% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
JARDIANCE 25 MG TABLET Empagliflozin | 00597015390 | $11.1897 per EA | +0.04% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
JARDIANCE 10 MG TABLET Empagliflozin | 00597015230 | $11.1893 per EA | +0.01% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
JARDIANCE 10 MG TABLET Empagliflozin | 00597015237 | $11.1893 per EA | +0.01% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
JARDIANCE 10 MG TABLET Empagliflozin | 00597015290 | $11.1893 per EA | +0.01% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
INVOKAMET XR 50-1,000 MG TAB canagliflozin and metformin hydrochloride | 50458094101 | $9.6876 per EA | — | | — | Janssen Pharmaceuticals Inc. |
INVOKAMET XR 50-500 MG TABLET canagliflozin and metformin hydrochloride | 50458094001 | $9.6775 per EA | — | | — | Janssen Pharmaceuticals Inc. |
INVOKAMET 150-500 MG TABLET canagliflozin and metformin hydrochloride | 50458054260 | $9.6089 per EA | — | | — | Janssen Pharmaceuticals Inc. |
XIGDUO XR 2.5 MG-1,000 MG TAB dapagliflozin and metformin hydrochloride | 00310622560 | $9.6082 per EA | +0.06% | | — | AstraZeneca Pharmaceuticals LP |
XIGDUO XR 5 MG-1,000 MG TABLET dapagliflozin and metformin hydrochloride | 00310626060 | $9.5924 per EA | +0.02% | | — | AstraZeneca Pharmaceuticals LP |
INVOKAMET 150-1,000 MG TABLET canagliflozin and metformin hydrochloride | 50458054360 | $9.5754 per EA | -0.01% | | — | Janssen Pharmaceuticals Inc. |
INVOKAMET 50-500 MG TABLET canagliflozin and metformin hydrochloride | 50458054060 | $9.5636 per EA | -0.05% | | — | Janssen Pharmaceuticals Inc. |
INVOKAMET XR 150-500 MG TABLET canagliflozin and metformin hydrochloride | 50458094201 | $9.5612 per EA | 0.00% | | — | Janssen Pharmaceuticals Inc. |
INVOKAMET 50-1,000 MG TABLET canagliflozin and metformin hydrochloride | 50458054160 | $9.5383 per EA | -0.01% | | — | Janssen Pharmaceuticals Inc. |
INVOKAMET XR 150-1,000 MG TAB canagliflozin and metformin hydrochloride | 50458094301 | $9.5358 per EA | +0.07% | | — | Janssen Pharmaceuticals Inc. |
TRIJARDY XR 5-2.5-1,000 MG TAB empagliflozin, linagliptin, metformin hydrochloride | 00597039523 | $5.6686 per EA | +0.08% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
TRIJARDY XR 5-2.5-1,000 MG TAB empagliflozin, linagliptin, metformin hydrochloride | 00597039582 | $5.6686 per EA | +0.08% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
TRIJARDY XR 12.5-2.5-1,000 MG empagliflozin, linagliptin, metformin hydrochloride | 00597038577 | $5.6277 per EA | +0.04% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
TRIJARDY XR 12.5-2.5-1,000 MG empagliflozin, linagliptin, metformin hydrochloride | 00597038586 | $5.6277 per EA | +0.04% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY 5-500 MG TABLET empagliflozin and metformin hydrochloride | 00597015918 | $5.6227 per EA | +0.09% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY 5-500 MG TABLET empagliflozin and metformin hydrochloride | 00597015960 | $5.6227 per EA | +0.09% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY 12.5-500 MG TABLET empagliflozin and metformin hydrochloride | 00597018018 | $5.6131 per EA | +0.09% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY 12.5-500 MG TABLET empagliflozin and metformin hydrochloride | 00597018060 | $5.6131 per EA | +0.09% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY XR 5-1,000 MG TABLET empagliflozin, metformin hydrochloride | 00597029059 | $5.6111 per EA | 0.00% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY XR 5-1,000 MG TABLET empagliflozin, metformin hydrochloride | 00597029074 | $5.6111 per EA | 0.00% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY 12.5-1,000 MG TABLET empagliflozin and metformin hydrochloride | 00597016818 | $5.6013 per EA | +0.02% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY 12.5-1,000 MG TABLET empagliflozin and metformin hydrochloride | 00597016860 | $5.6013 per EA | +0.02% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY 5-1,000 MG TABLET empagliflozin and metformin hydrochloride | 00597017518 | $5.5994 per EA | +0.03% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY 5-1,000 MG TABLET empagliflozin and metformin hydrochloride | 00597017560 | $5.5994 per EA | +0.03% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY XR 12.5-1,000 MG TAB empagliflozin, metformin hydrochloride | 00597030045 | $5.5980 per EA | +0.02% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
SYNJARDY XR 12.5-1,000 MG TAB empagliflozin, metformin hydrochloride | 00597030093 | $5.5980 per EA | +0.02% | | — | Boehringer Ingelheim Pharmaceuticals Inc. |
DAPAGLIFLOZIN-METFORMIN ER 10-1,000 MG TABLET dapagliflozin and metformin hydrochloride | 66993036230 | $0.7195 per EA | — | | — | Prasco Laboratories |
DAPAGLIFLOZIN-METFORMIN ER 5-1,000 MG TABLET dapagliflozin and metformin hydrochloride | 66993036160 | $0.4606 per EA | — | | — | Prasco Laboratories |
DAPAGLIFLOZIN 10 MG TABLET DAPAGLIFLOZIN | 66993045730 | $0.1839 per EA | — | | — | Prasco Laboratories |
DAPAGLIFLOZIN 5 MG TABLET DAPAGLIFLOZIN | 66993045630 | $0.1627 per EA | — | | — | Prasco Laboratories |